MedTrace Logo

Platelet Rich Fibrin for Tear Trough Rejuvenation

NCT03313934 · Status: UNKNOWN · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2017-10-18

No results posted yet for this study

Summary

The purpose of this study is to investigate the efficacy and longevity of Platelet Rich Fibrin (PRF) in combination with hyaluronic acid filler for cosmetic volume restoration of the tear troughs. This study will also evaluate visible improvement in skin texture that may be attributable to the added PRF.

Conditions

  • Tear Trough Hollowing, Under Eye Bags

Interventions

COMBINATION_PRODUCT

Hyaluronic Acid Filler and Platelet Rich Fibrin (PRF)

The use of Restylane-L to volumize the tear trough has been well documented. Combining Restylane-L with Platelet Rich Fibrin (PRF) will be studied to evaluate if PRF enhances the volumization and skin quality of the treated areas.

COMBINATION_PRODUCT

Hyaluronic Acid Filler and Saline

This intervention will use saline as a control to compare with PRF when mixed with hyaluronic acid fillers. Saline will dilute the HA filler in the same way PRF will, however saline as no growth factors or properties that will enhance treatment.

Sponsors & Collaborators

  • Rejuva Medical Aesthetics

    lead OTHER

Principal Investigators

  • Kian Karimi, MD,FACS · Rejuva Medical Aesthetics

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-11-30
Primary Completion
2018-11-30
Completion
2018-11-30
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03313934 on ClinicalTrials.gov